Researchers at MIT have uncovered a powerful way the brain "unlearns" fear: through a dopamine-driven reward signal. By ...

Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, ...

An investigative history of the scandal-plagued company shines a light on a health care industry riddled with corruption and ...

With the future of her cancer treatment in limbo, Natalie Phelps doesn’t know how much longer she can wait. Last month, after months of seeking treatment options for her colorectal cancer, the 43-year ...

a dopamine D1/D5 partial agonist in phase 3 testing as a treatment for Parkinson’s disease, and darigabat, an α2/3/5-selective GABAA receptor PAM in mid-stage testing for epilepsy and panic ...

SUNDAY, May 11, 2025 (HealthDay News) — Why does sugar taste so good — and why do we want it so badly? Scientists may finally ...

Resurrection of ancient forms of CD4 reveals how retroviruses have placed selective pressure on this gene in apes, acting to propagate infection-resistant alleles.

Novo Nordisk's GLP-1 receptor agonist semaglutide has been shown to help people struggling with alcohol use disorder (AUD) reduce the amount they drink – pointing to yet another potential use ...

Cerebellar mf-GoC synapses show anti-symmetric STDP, driven by action potential timing, NMDA receptor activation, and Ca²⁺ dynamics, with inhibitory input capable of reversing the plasticity rules.

Reductions in alcohol intake noted in high and low consumers; no significant difference seen in percentage reductions for men and women ...